IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Austria

  • ID: 1408473
  • Report
  • Region: Austria
  • 46 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Health Insurance System
  • Regulation and Funding
  • Ambulatory and Hospital Care

2. Pricing

  • Prescription Drugs
  • Reimbursed Drugs
  • Non-reimbursed Drugs
  • Generic Drugs
  • Generics
  • Biosimilars
  • Actual Prices
  • Hospital Drugs
  • Actual Prices
  • Discounts
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Application
  • Process
  • Decision
  • Appeals
  • Individual Reimbursement
  • Reimbursement Categories
  • Reimbursement ‘Box’ System
  • Non-reimbursed Drugs
  • Reimbursement Prices
  • Hospital Reimbursement
  • Formularies
  • Funding
  • Changes in Reimbursement Status
  • Manufacturers’ Applications
  • HVB
  • Changes in Reimbursement Prices
  • Red Box
  • Green/Yellow Boxes
  • Off-Patent Originals and Generics
  • Biologics and Biosimilars

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements

5. Price Build Up

  • Wholesalers
  • Margins
  • Discounts
  • Background
  • Retail Pharmacies
  • Margins
  • Discounts and Rebates
  • Background
  • E-pharmacy
  • Other Developments
  • Drugstores
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Patient Co-payments
  • Pharmaceuticals
  • Healthcare
  • Prescribing Controls
  • National Level
  • Upper Austria
  • Salzburg and Burgenland
  • Vienna
  • Generics
  • INN Prescribing and Generic Substitution
  • Generics Promotion
  • Rx-to-OTC Switches
  • Switches
  • OTC Market
  • Parallel Trade

7. Future Developments

  • Outlook
  • Pricing Reform
  • Debt/Surplus Management
  • Healthcare Reform
  • ELGA Implementation

8. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll